[ Trice Medical raises $19.3M in Series C funding ]
Trice Medical has raised $19.3 million in Series C funding.
Founded in 2011, Trice Medical focuses on developing orthopedic diagnostics devices with integrated camera-enabled technologies for patients, physicians and payors.
The round will go toward accelerating and expanding the company’s U.S. market reach for its flagship product, a handheld diagnostics tool called mi-eye, as well as research and development, sales, marketing and key international regulatory approvals.
|City||King Of Prussia, Pennsylvania|
|Founder / CEO||Jeffrey F. O’Donnell|
|Investors||Smith & Nephew|
|Previous Investors||BioStar Ventures|